دورية أكاديمية

Combination of Copeptin and Troponin Assays to Rapidly Rule Out Non-ST Elevation Myocardial Infarction in the Emergency Department.

التفاصيل البيبلوغرافية
العنوان: Combination of Copeptin and Troponin Assays to Rapidly Rule Out Non-ST Elevation Myocardial Infarction in the Emergency Department.
المؤلفون: Charpentier, Sandrine, Maupas-Schwalm, Françoise, Cournot, Maxime, Elbaz, Meyer, Botella, Jean Marie, Lauque, Dominique
المصدر: Academic Emergency Medicine; May2012, Vol. 19 Issue 5, p517-524, 8p
مصطلحات موضوعية: DIABETES complications, MYOCARDIAL infarction diagnosis, MYOCARDIAL infarction risk factors, BIOMARKERS, COMBINATION drug therapy, CONFIDENCE intervals, DRUG design, CLINICAL drug trials, ELECTROCARDIOGRAPHY, EMERGENCY medicine, HOSPITAL emergency services, LONGITUDINAL method, MEDICAL societies, COMORBIDITY, BODY mass index, TROPONIN, DESCRIPTIVE statistics
مستخلص: ACADEMIC EMERGENCY MEDICINE 2012; 19: 517-524 © 2012 by the Society for Academic Emergency Medicine Abstract Objectives: The aim of this study was to analyze the diagnostic accuracy and the clinical usefulness of the combination of troponin I (cTnI) and copeptin measured at presentation with an automated assay to rapidly rule out non-ST elevation myocardial infarction (NSTEMI) in patients with suspected cardiac chest pain presenting to an emergency department (ED). Methods: This study was an ancillary analysis of a prospective observational study. Copeptin and cTnI levels were sampled at presentation in 641 consecutive patients admitted to the ED for chest pain with onset within the last 12 hours and without ST elevation on a 12-lead electrocardiogram (ECG). Copeptin was measured with an automated assay and troponin with conventional assay. The performance of a combination of cTnI and copeptin for NSTEMI diagnosis was studied, the clinical utility was assessed by multivariate analysis, and an area under the curve (AUC) calculation was used to determine accuracy. Results: NSTEMI was diagnosed in 95 patients (15%). The sensitivity and negative predictive value (NPV) of the combination of copeptin and cTnI measures were 90.4% (95% confidence interval [CI] = 88.2% to 92.7%) and 97.6% (95% CI = 96.4% to 98.7%) versus 55.3% (95% CI = 51.5% to 59.2%) and 92.8% (95% CI = 90.8% to 94.8%) with cTnI alone. The AUC of the combination of copeptin and cTnI was 0.89 (95% CI = 0.85% to 0.92%) and was significantly higher than the AUC of cTnI alone (0.77, 95% CI = 0.72% to 0.82%, p < 0.05). The patient classification was slightly improved when copeptin was added to the usual diagnostic tools used for NSTEMI management. Conclusions: In this study, determination of copeptin, in addition to cTnI, improves early diagnostic accuracy of NSTEMI. However, the sensitivity of this combination even using a conventional troponin assay remains insufficient to safely rule out NSTEMI at the time of presentation. [ABSTRACT FROM AUTHOR]
Copyright of Academic Emergency Medicine is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:10696563
DOI:10.1111/j.1553-2712.2012.01350.x